Diabetes-Related Chronic Kidney Disease
October 13, 2022 -
 January 26, 2022
Select Thursdays
7:30 AM -
 8:30 AM
Register Now

Currently 1 in 10 adults in the United States have diabetes, 1 in 3 with diabetes have chronic kidney disease (CKD), and 3 in 4 with Diabetes-Related Kidney Disease (DKD) are unaware*.  Healthcare disparities including racial, ethnic, and socioeconomic factors further impact the quality of care for patients with CKD.

Join us to address the urgent and persistent needs of underserved populations of people with diabetes complicated by chronic kidney disease.

Led by a multidisciplinary panel of diabetes and renal experts, we seek to increase your skills to screen, diagnose, and manage the renal complications of diabetes to address disparities and advance health equity in people with Diabetes-Related CKD.

All providers working in a Federally Qualified Health Care Center (FQHC), Rural Health Center, Indian Health Service Center, or other Health Center Look-Alike are encouraged to participate with members of your primary care team.

*Resources: CDC Chronic Kidney Disease 2021

Series Leaders

  • Louis Amorosa, MD, Endocrinologist, Rutgers Robert Wood Johnson Medical School
  • Mary Bridgeman, PharmD, BCPS, BCGP, Clinical Professor, Rutgers Ernest Mario School of Pharmacy, Internal Medicine Clinical Pharmacist, Robert Wood Johnson University Hospital
  • Judith Hamilton, Peer Educator, Patient Advocate, Trenton Health Team
  • Eric Jahn, MD, Senior Associate Dean for Community Health, Rutgers Robert Wood Johnson Medical School
  • Steve Khalil, MD, Nephrologist, Rutgers Robert Wood Johnson Medical School
  • Lee Ruszczyk, LCSW, CCS, ACS, Senior Director Behavioral Health, Henry J. Austin Health Center
  • Julie Valdes, PharmD, CDCES, CTTS, Clinical Pharmacist, Whole Family Health Center

Learning Objectives

After participating in this ECHO, providers will be able to:

  • Describe evidence- and guideline-based processes for screening for renal disease among patients with type 2 diabetes
  • Utilize evidence-based, collaborative strategies to design and implement individualized diabetes management strategies which consider both glycemic and non-glycemic targets
  • Design care plans that incorporate effective patient education and empowerment

Continuing Education Accreditation

To view the CE Accreditation for CME, CNE, CPE, and Social Work Credits, click here.

Additional Information

This ECHO is made possible by support from the ECHO Diabetes Action Network (EDAN). EDAN works to combat systems failure for underserved patients with diabetes through education and quality improvement. EDAN has identified Rutgers Project ECHO as a partner in implementing this ECHO program, with content designed to amplify the call-to-action to eradicate disparities in treating diabetes and CKD.

Sessions

Addressing CKD Disparities & Social Determinantsof Health to Achieve Diabetes Management Goals
Thursday • October 13, 2022
7:30 AM
- 8:30 AM
Glucose Control: Best Practices to AddressDiabetes-Related CKD
Thursday • October 27, 2022
7:30 AM
- 8:30 AM
Approaches to Identifying CKD & The New Kidney Health Evaluation
Thursday • November 10, 2022
7:30 AM
- 8:30 AM
SGLT2 Inhibitors and GLP-1 Agonists: Diabetes Agents that Improve Renal Outcomes
Thursday • November 17, 2022
7:30 AM
- 8:30 AM
Halting CKD Progression: From Optimizing Hypertension Management to Newer Agents
Thursday • December 01, 2022
7:30 AM
- 8:30 AM
Primary Care Provider Interventions to Arrest CKD Progression
Thursday • December 15, 2022
7:30 AM
- 8:30 AM
CKD & Renal Transplant Disparities
Thursday • January 05, 2023
7:30 AM
- 8:30 AM
Management of CKD: The Patient’s Perspective
Thursday • January 26, 2023
7:30 AM
- 8:30 AM

© 2023 All rights reserved​

Rutgers Project ECHO is administered by Rutgers Robert Wood Johnson Medical School with generous support from NJ Department of Health, NJ Department Human Services, and other funders.